Glypican-1 is a novel immunohistochemical marker to differentiate poorly differentiated squamous cell carcinoma from solid predominant adenocarcinoma of the lung

BACKGROUND: The histological classification of non-small cell lung cancer (NSCLC) is essential in determining new cancer-specific targeted therapies. However, the accurate typing of poorly differentiated is difficult, particularly for poorly differentiated squamous cell carcinoma and adenocarcinoma...

Full description

Saved in:
Bibliographic Details
Published in:Transl Lung Cancer Res
Main Authors: Kai, Yuichiro, Amatya, Vishwa Jeet, Kushitani, Kei, Kambara, Takahiro, Suzuki, Rui, Fujii, Yutaro, Tsutani, Yasuhiro, Miyata, Yoshihiro, Okada, Morihito, Takeshima, Yukio
Format: Artigo
Language:Inglês
Published: AME Publishing Company 2021
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7947391/
https://ncbi.nlm.nih.gov/pubmed/33718020
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr-20-857
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items